만성 난치성 기침에 대한 기침 억제 요법의 효과
The Benefit of Supplemental Cough Suppression Therapy for Chronic Refractory Cough
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives Cough suppression therapy (CST) is a physiotherapy that can be used for patients with chronic refractory cough (CRC). We aimed to investigate the efficacy of CST for CRC.Materials and Method A prospective randomized controlled trial was conducted in 27 patients with CRC. Participants were randomized to receive either standard mucolytic medications for CRC combined with supplemental CST (CST group) or standard medications alone (control group). CST consists of laryngeal hygiene management, humidification, cough suppression technique, breathing method, and counseling. We assessed the symptoms change at baseline and week 4 with the Leicester Cough Questionnaire (LCQ). Secondary efficacy outcomes included the degree of cough Visual Analog Scale (VAS) score (0 to 100 scale).Results From 2019 to 2021, 14 CST group patients and 13 control group patients were included. The improvement was significantly greater in the CST group than in the control group for cough VAS score (36.67 to 13.33 vs. 74.29 to 16.43, p<0.001). Patients in the CST group had a significant improvement in total (70.14 to 107.71, p=0.005), physical (31.42 to 43.86, p= 0.015), psychological (23.57 to 40.14, p=0.003), and social (15.14 to 23.71, p=0.005) LCQ scores. However, there was not a significant pre- to post-treatment LCQ score improvement in control group.Conclusion CST might be an effective supplemental intervention for CRC.
Abstract
Background and Objectives Cough suppression therapy (CST) is a physiotherapy that can be used for patients with chronic refractory cough (CRC). We aimed to investigate the efficacy of CST for CRC.Materials and Method A prospective randomized controlled trial was conducted in 27 patients with CRC. Participants were randomized to receive either standard mucolytic medications for CRC combined with supplemental CST (CST group) or standard medications alone (control group). CST consists of laryngeal hygiene management, humidification, cough suppression technique, breathing method, and counseling. We assessed the symptoms change at baseline and week 4 with the Leicester Cough Questionnaire (LCQ). Secondary efficacy outcomes included the degree of cough Visual Analog Scale (VAS) score (0 to 100 scale).Results From 2019 to 2021, 14 CST group patients and 13 control group patients were included. The improvement was significantly greater in the CST group than in the control group for cough VAS score (36.67 to 13.33 vs. 74.29 to 16.43, p<0.001). Patients in the CST group had a significant improvement in total (70.14 to 107.71, p=0.005), physical (31.42 to 43.86, p= 0.015), psychological (23.57 to 40.14, p=0.003), and social (15.14 to 23.71, p=0.005) LCQ scores. However, there was not a significant pre- to post-treatment LCQ score improvement in control group.Conclusion CST might be an effective supplemental intervention for CRC.
참고문헌 (19)
- Morice AH, "Recommendations for the management of cough in adults", Thorax, 61(Suppl 1), pp.i1~24 (2006)
- Ford AC, "Cough in the community : A cross sectional survey and the relationship to gastrointestinal symptoms", Thorax, 61(11), pp.975~979 (2006)
- Brignall K, "Quality of life and psychosocial aspects of cough", Lung, 186(Suppl 1), pp.S55~S58 (2008)
- Chamberlain S, "Nonpharmacological interventions for refractory chronic cough patients : Systematic review", Lung, 192(1), pp.75~85 (2014)
- Haque RA, "Chronic idiopathic cough: A discrete clinical entity?", Chest, 127(5), pp.1710~1713 (2005)
- Morice AH, "Epidemiology of cough", Pulm Pharmacol Ther, 15(3), pp.253~259 (2002)
- Vertigan AE, "Efficacy of speech pathology management for chronic cough : A randomised placebo controlled trial of treatment efficacy", Thorax, 61(12), pp.1065~1069 (2006)
- Chamberlain S, "Cough suppression therapy:Does it work?", Pulm Pharmacol Ther, 26(5), pp.524~527 (2013)
- Gibson PG, "Speech pathology for chronic cough : A new approach", Pulm Pharmacol Ther, 22(2), pp.159~162 (2009)
- Birring SS, "Physiotherapy and speech and language therapy intervention for chronic cough", Pulm Pharmacol Ther, 47, pp.84~87 (2017)
- Birring SS, "Development of a symptom specific health status measure for patients with chronic cough : Leicester Cough Questionnaire(LCQ)", Thorax, 58(4), pp.339~343 (2003)
- Chamberlain Mitchell SAF, "Non-pharmacological interventions for chronic cough : The past, present and future", Pulm Pharmacol Ther, 56, pp.29~38 (2019)
- Gibson PG, "Management of chronic refractory cough", BMJ, 351, pp.h5590~ (2015)
- Ryan NM, "Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough", Cough, 6, pp.5~ (2010)
- Patel AS, "Improvement in health status following cough-suppression physiotherapy for patients with chronic cough", Chron Respir Dis, 8(4), pp.253~258 (2011)
- Chamberlain Mitchell SA, "Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough : A multicentre randomised control trial", Thorax, 72(2), pp.129~136 (2017)
- Mitchell SC, "Breathing pattern changes in refractory chronic cough with physiotherapy speech and language therapy intervention", Eur Respir J, 48(suppl 60), pp.PA1375~ (2016)
- Kapela SL, "Speech pathology intervention for chronic refractory cough : A pilot study examining the benefit of using prerecorded videos as an adjunct to therapy", J Voice, 34(4), pp.647~ (2020)
- Slovarp LJ, "Evaluation and management outcomes and burdens in patients with refractory chronic cough referred for behavioral cough suppression therapy", Lung, 199(3), pp.263~271 (2021)
